Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ATRA
CTOR
Add up to 3 more stocks
ATRA
Atara Biotherapeutics, Inc.
+2.23%
$9.61+0.21Delayed quote: Oct 6, 2026, 10:44 AM EDT
Market Cap
$86.59M
52W Range
$3.92 - $19.15
CTOR
Citius Oncology, Inc.
+0.74%
$0.88+0.01Delayed quote: Oct 6, 2026, 10:40 AM EDT
Market Cap
$81.82M
52W Range
$0.49 - $2.25
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | 8.80 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | N/A | 2.03 |
| P/S Ratio | 13.98 | 11.52 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 82.4% | 0.0% |
| Operating Margin | 29.7% | 0.0% |
| Net Margin | -269.4% | -648.3% |
| ROE | N/A | -114.1% |
| ROA | -79.4% | -41.1% |
| ROIC | -100.3% | -88.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.98 | 0.73 |
| Quick Ratio | 1.98 | 0.34 |
| Debt/Equity | N/A | 0.25 |
| Interest Coverage | 9.46 | -107.89 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.